Firefly Neuroscience

2024 has been an eventful year for Firefly Neuroscience! After closing our merger transaction and beginning to trade on the NASDAQ under “AIFF” in August, we’ve continued to advance our AI-driven BNA platform and entered into partnerships that employ our technology as a tool to aid in clinical research and neurological care. Here are some of the highlights: We formed a strategic partnership with Neurology Consultants of Dallas to enhance early detection efforts and disease management for patients with cognitive disorders using BNA. Firefly teamed up with Zeto / Rapid Full-Montage EEG to integrate our technology with the Company’s advanced EEG platform and distribute its FDA-cleared EEG headset devices, cloud platform and services. Bright Minds Biosciences utilized Firefly’s BNA to analyze the data from its first-in-human Phase 1 study of its lead compound, BMB-101, for the targeted treatment of neuropsychiatric disorders and refractory epilepsy. We also collaborated to provide a full analysis of the EEG data in the Company’s BREAKTHROUGH study. BNA will be used to support Arrivo BioVentures LLC’s Phase 1 exploratory study of its first-in-class SIRT activator, SP-624, the first potential treatment designed for women with Major Depressive Disorder. Thanks to the Firefly team and all of our partners for an incredible year. We can’t wait to see what 2025 brings!

Forbes lists personalized healthcare as one of the primary healthcare trends that will drive advancements in healthcare next year. With new, AI-driven tools, healthcare providers can unlock powerful insights and tailor care to each patient. Our FDA-cleared technology platform, BNA™, harnesses the power of AI to provide healthcare professionals an unparalleled understanding of brain activity, allowing them to customize treatment plans and promote better patient outcomes. https://lnkd.in/ehKA4QSY #Healthcare #ArtificialIntelligence #Neuroscience #BrainHealth #AIinHealthcare

Firefly’s FDA-cleared BNA™ platform is powered by advanced AI technology that transforms vast EEG data into critical insights to continuously refine clinicians’ understanding and treatment of neurological conditions. Developed using a proprietary, standardized database encompassing scans from over 17,000 individuals, Firefly’s technology provides extensive data-driven assessments of brain activity to help drive neurological research and personalized care. Learn more: https://fireflyneuro.com/ #Healthcare #ArtificialIntelligence #Neuroscience #BrainHealth #AIinHealthcare

Our Director of National Accounts, Laura S., is joining Zeto / Rapid Full-Montage EEG this weekend at the American Epilepsy Society’s Annual Meeting at the Los Angeles Convention Center. Stop by Zeto Booth #1219 on December 7 and 8 from 1 – 2 pm to hear about our AI-driven BNA™ technology and discover how our partnership with Zeto can advance care for epilepsy and other neurological conditions. #AES2024 #Neurology #EEG #Healthcare #ArtificialIntelligence

With Firefly’s AI-powered BNA™ platform, healthcare providers can extract next-generation brain health insights from a simple recording session. After measuring brain activity at rest and during a series of cognitive tasks, the platform uploads information to the cloud, where our patented AI algorithms perform advanced analysis to establish personalized cognitive measures. These measures are then compared to our extensive age-matched normative database to equip healthcare professionals with an objective assessment of each patients’ brain activity. Get started today: https://lnkd.in/dFfvAem4 #Healthcare #ArtificialIntelligence #Neuroscience #BrainHealth #AIinHealthcare

How does Firefly’s BNA™ technology unlock a deeper understanding of brain activity? Every psychiatric and neurological condition is unique, and some conditions only affect task performance at more progressed stages or during complex tasks. Our BNA™ platform Behavioral Report helps clinicians and neurologists better understand the severity and progression of each patient’s condition, unlocking a deeper understanding of brain activity. Learn more about how BNA™can transform your practice: https://lnkd.in/emHuWVVU #Healthcare #ArtificialIntelligence #Neuroscience #BrainHealth #AIinHealthcare

Our CEO, Jon Olsen, sat down with Authority Magazine to discuss his passion for developing innovative technologies, Firefly’s work to disrupt the standard of neurological care and what’s ahead for the company in 2025. “I believe what we are doing at Firefly will disrupt the standard of care and improve outcomes for patients suffering from brain health illnesses and disorders by providing clinicians with the ability to objectively assess brain health,” he shared. Read more: https://lnkd.in/eNq26FWn    #Innovation #HealthcareTechnology #ArtificialIntelligence #Neuroscience #BrainHealth

Firefly’s BNA™ technology has the potential to revolutionize brain health by allowing healthcare providers to track disease progression over time and evaluate the effectiveness of treatments. With BNA™’s advanced, AI-driven technology, clinicians and neurologists can compare a patient’s current results to baseline measurements in the initial report in order to monitor progress and personalize treatment plans. Ready to harness the power of BNA™? Contact us: https://lnkd.in/gJ_2ngYx    #Healthcare #ArtificialIntelligence #Neuroscience #BrainHealth #AIinHealthcare

Firefly Neuroscience’s BNA™ is poised to revolutionize the brain healthcare industry through our unique AI capabilities and next generation neurological insights. BNA™’s AI-based EEG analysis encompasses ERP, quantitative spectral EEG and behavioral results – all in one FDA-cleared tool. Unlike the current standard of neurological care, which often relies on manual interpretation and a trial and error treatment approach, our advanced technology allows for a deeper understanding of brain activity by providing quantifiable, data-driven insights. Discover how you can integrate BNA™ into your practice to improve patient care and drive better outcomes: https://lnkd.in/dFfvAem4 #Healthcare #ArtificialIntelligence #Neuroscience #BrainHealth #AIinHealthcare

How is Firefly driving the future of neurological assessments and personalized brain health care? Our FDA-cleared BNA™ platform equips healthcare professionals with comprehensive insights into neural activity by leveraging Event Related Potentials (ERPs), quantitative spectral EEG, behavioral results and advanced AI analysis. This objective assessment provides clinicians and neurologists with a deeper understanding of each patient’s brain function that allows them to tailor treatments according to their unique needs. Learn more about BNA™ and its potential to revolutionize neurological care: https://fireflyneuro.com/ #Healthcare #ArtificialIntelligence #Neuroscience #BrainHealth #AIinHealthcare